Compound ID | 3648
BC-7013
Synonym(s): BC7013 | BC 7013
Class: Pleuromutilin
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against methicillin-resistant and -susceptible Staphylococcus aureus, coagulase-negative staphylococci, and beta-haemolytic streptococci |
| Description: | Evaluated for topical formulation |
| Institute where first reported: | JMI Laboratories (USA); Nabriva Therapeutics AG (Austria) |
| Year first mentioned: | 2009 |
| Development status: | Experimental |
| External links: | |
| Guide to Pharmacology: | BC-7013 |
| Citation: | https://www.jmilabs.com/data/posters/ICAAC2009/F1-1521.PDF |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.